Subscribe To
Should vanguard s&p mid-cap 400 growth etf (ivog) be on your investing radar?
Looking for broad exposure to the Mid Cap Growth segment of the US equity market? You should consider t...
October 16, 2023, 7:31 am
Should vanguard growth etf (vug) be on your investing radar?
Launched on 01/26/2004, the Vanguard Growth ETF (VUG) is a passively managed exchange traded fund designed to provide a ...
October 16, 2023, 7:31 am
Should you invest in the ishares u.s. utilities etf (idu)?
Looking for broad exposure to the Utilities - broad segm...
October 16, 2023, 7:31 am
Should you invest in the first trust energy alphadex etf (fxn)?
Launched on 05/08/2007, the First Trust Energy AlphaDEX ETF (FXN) is a passively managed exchange traded fund designed to provide a ...
October 16, 2023, 7:31 am
Is spdr russell 1000 low volatility focus etf (onev) a strong etf right now?
The SPDR Russell 1000 Low Volatility Focus ETF (ONEV) was launched on 12/02/2015, and is a smart beta exchange traded fund designed to offer ...
October 16, 2023, 7:31 am
Is first trust nasdaq-100 equal weighted etf (qqew) a strong etf right now?
The First Trust NASDAQ-100 Equal Weighted ETF (QQEW) was launched on 04/19/2006, and is a smart beta exchange traded fund designed to offer ...
October 16, 2023, 7:31 am
Should ishares s&p small-cap 600 value etf (ijs) be on your investing radar?
If you're interested in broad exposure to the Small Cap Value segment of the US equity market, look no ...
October 16, 2023, 7:31 am
Assessing the wise & impact covid-19 commercial real estate
The post Assessing the wise & impact COVID-19 commercial real estate appeared first on Financebrokerage...
October 16, 2023, 7:17 am
Navigating future of defense technology, strategy & security
The post Navigating Future of Defense Technology, Strategy & Security appeared first on Financebrokerag...
October 16, 2023, 7:12 am
Eu expansion objectives, advantages, challenges & prospects
The post EU Expansion Objectives, Advantages, Challenges & Prospects appeared first on Financebrokerage...
October 16, 2023, 7:08 am
Johnson & johnson: a conservative high-yield dividend aristocrat buy
Johnson & Johnson is a defensive pick with a renewed focus on its pharmaceutical and medtech segments. The recent selloff in the stock has ...
October 16, 2023, 7:05 am
Usd/cad attracts some sellers below 1.3660 amid the rebound in oil prices, canadian cpi, us retail sales eyed
EUR/USD is attracting some buyers above 1.0500 amid a broadly softer US Dollar early Monday. Further up...
October 16, 2023, 6:29 am
Eurostoxx futures flat in early european trading
German DAX futures flatUK FTSE futures +0.2%The declines last week are balanced out by slight gains in US futures today. S&P 500 futures are up 0.2% c...
October 16, 2023, 6:08 am
Markets tread carefully, geopolitics to overshadow inflation and retail sales data
Financial markets are holding steady yet exhibit a sense of nervous anticipation as the new week commences. The conflicts between Israel and Hamas con...
October 16, 2023, 5:40 am
K-bro linen declares cad 0.10 dividend
K-bro Linen (KBRLF) declares CAD 0.10/share monthly dividend, in line with previous. Forward yield 3.54...
October 16, 2023, 4:59 am
Pfizer's sequel: return of the value stock
Pfizer is focusing on its core growth engines and strategic acquisitions, particularly in the oncology segment, to compensate for downgraded revenue p...
October 16, 2023, 2:53 am
Arrow ec income advantage alternative fund declares cad 0.081 dividend
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. Is...
October 16, 2023, 2:44 am
Rite aid files for bankruptcy
Rite Aid filed for Chapter 11 bankruptcy protection Sunday, after being embroiled in legal battles for ...
October 15, 2023, 11:45 pm
Jp morgan ceo dimon: "this may be the most dangerous time the world has seen in decades"
JP Morgan CEO Jamie Dimon noted on the firm's Q3 earnings releasethe war in Ukraine compounded by last week’s attacks on Israel may have far-reachin...
October 15, 2023, 10:36 pm
Gilead sciences stock is cheap, with broad pipeline
Gilead Sciences is a California-based biopharmaceutical company with a $95 billion market cap, known for its treatments in HIV, hepatitis B, hepatitis...
October 15, 2023, 9:45 pm